Scaling Up For First Product Launch: Seven Hazards To Avoid
Launching The First Product Is One Of The Most Challenging Transitions For A Biopharma
Executive Summary
As the margin for error in the drug launch cycle continues to erode, emerging biopharma companies face a growing urgency to double down on scaling up for their first launch.